跳至主要内容
临床试验/CTRI/2025/08/093375
CTRI/2025/08/093375尚未招募3 期

Evaluating the effectiveness of Oral Individualized Homoeopathic Medicines Versus Hydrastis Canadensis Tincture as a local application in the treatment of Bacterial Vaginosis: An open label Randomized Controlled Clinical Trial

Dr Divya Bharti1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2025年9月1日最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
60
试验地点
1
主要终点
1. This trial is expected to indicate that individualized homoeopathic medicines will have greater

研究概览

简要总结

This study compares the effectiveness of individualized homoeopathic medicines and local hydrastis canadensis tincture with placebo in treating patients with Bacterial Vaginosis, aged 18-45 years. Patients will be randomly assigned to receive either individualized homoeopathic medicines or local hydrastis canadensis tincture with placebo.The study will measure the outcomes using Amsel’s criteria, Nugent scoring and vaginal discharge assessment form. The results will provide valuable insights into the effectiveness of homoeopathic approaches in treating Bacterial Vaginosis.

研究设计

研究类型
Interventional

入排标准

年龄范围
18.00 Year(s) 至 45.00 Year(s)(—)
性别
Female

入选标准

  • women of age group 18-45 years.
  • Women presenting with sign and symptoms of Bacterial Vaginosis as per Amsel’s and Nugent Scoring.

排除标准

  • Pregnancy or Lactation: Women who are pregnant or breastfeeding.
  • Concurrent Vaginal Infections: Presence of other sexually transmitted infections.
  • Severe Comorbidities: Significant medical conditions (e.g., diabetes, immunosuppression) that could affect treatment outcomes.
  • Recent Surgical Procedures: Any recent gynecological surgeries or interventions.
  • Hormonal Treatments: Use of hormonal therapies (e.g., contraceptives, hormone replacement therapy) that may influence vaginal flora.
  • Uncontrolled Medical Conditions: Any uncontrolled systemic conditions that could impact health or treatment efficacy.
  • Allergies to Study Remedies: Known allergies or sensitivities to any homoeopathic remedies being tested.
  • Non-compliance Risk: Individuals who may not adhere to the study protocol or followup requirements.

结局指标

主要结局

1. This trial is expected to indicate that individualized homoeopathic medicines will have greater

时间窗: 11 months

therapeutic benefits as compared to Hydrastis Canadensis in treatment of Bacterial Vaginosis

时间窗: 11 months

次要结局

  • 1.This study aims to identify a group of most effective homeopathic medicine in the management of Bacterial Vaginosis(2.The study anticipates that homeopathic medicine will show positive effects by improving Amsel’s criteria and Nugent’s score in the treatment of Bacterial Vaginosis)

研究者

发起方
Dr Divya Bharti
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Divya Bharti

Dr B R Sur Homoeopathic Medical College Hospital and Research Centre

研究点 (1)

Loading locations...

相似试验